SEHK:1875Biotechs
BioDlink International (SEHK:1875) Small FY 2025 H1 Profit Tests Bearish Loss Narratives
BioDlink International (SEHK:1875) has opened FY 2025 with first half revenue of C¥489.1 million and basic EPS of C¥0.0056, setting a very different tone from the trailing 12 month result, where revenue was C¥747.6 million and the company booked a net loss of C¥100.4 million with basic EPS of C¥0.14. Over recent periods, revenue has moved between C¥520.6 million and C¥577.7 million across FY 2024 halves while basic EPS shifted from C¥0.0435 in 2024 H1 to C¥0.0044 in 2024 H2 and then to...